Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression

By afschroeder • April 30, 2026

Hoover PJ, Eisenhaure TM, Hodgin J, Apruzzese W, Mears J, Peters M, Jones T, Shah SI, Kamal H, Leavitt R, Jackson SW, Danaher P, Rao DA, Xiao Q, Gurajala S, Ai J, Fava A, Berthier CC, Horisberger A, Barnas JL, Izmirly PM, Belmont HM, Clancy R, Furie R, Aranow C, Guthridge JM, Dall'Era M, Wofsy D, Kamen DL, Kalunian KC, McMahon MA, Grossman J, Payan-Schober F, Hildeman DA, Woodle ES, Putterman C, Kretzler M, Clark MR, Raychaudhuri S, James JA, Anolik JH, Petri MA, Buyon JP; Accelerating Medicines Partnership (AMP) RA/SLE Network; Diamond B, Davidson A, Hacohen N, Arazi A. Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression. Ann Rheum Dis. 2026 Apr 28:S0003-4967(26)00149-4. doi: 10.1016/j.ard.2026.03.004. Epub ahead of print. PMID: 42055919.

Tags: Publications, Rheumatology

Progressive Muscle Rigidity and Spasms in an Older Adult: A Diagnostic Challenge

Leonard SD, Tran HT. Progressive Muscle Rigidity and Spasms in an Older Adult: A Diagnostic Challenge. Cureus. 2026 Apr 2;18(4):e106329. doi: 10.7759/cureus.106329. PMID: 42078214; PMCID:[...]

Achieving timely treatment for early-stage non-small cell lung cancer: Factors associated with delayed surgical resection and proposed quality benchmarks

Tupper HI, Bhattacharjee J, Sarovar V, Amara D, Schmittdiel JA, Quesenberry CP, Cummings AL, Velotta JB, Sakoda LC. Achieving timely treatment for early-stage non-small cell[...]

Impact of UGT1A1*28 polymorphism in patients with metastatic pancreatic ductal adenocarcinoma treated with NALIRIFOX in the NAPOLI 3 trial

Abdelrahim M, Khan G, Hatoum H, Zervoudakis A, Dayyani F, Zhang L, Li J, Maxwell F, O'Reilly EM, Wainberg ZA, Bullock A. Impact of UGT1A1*28polymorphism in[...]